-
Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis.
Gastro Hep AdvancesJelinsky S, Lee I, Monetti M, Breitkopf S, Martz F, Kongala R, Culver J, Vo V, Xue L, Gieseck R 3rd, Dickinson C, Kasaian M, Lord JD -
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.
Nature Reviews. RheumatologyHolers VM, Demoruelle KM, Buckner JH, James EA, Firestein GS, Robinson WH, Steere AC, Zhang F, Norris JM, Kuhn KA, Deane KD -
Fc-Engineered Antibodies Promote Neutrophil-Dependent Control of Mycobacterium Tuberculosis
Nat MicrobiolIrvine EB, Nikolov A, Khan MZ, Peters JM, Lu R, Sixsmith J, Wallace A, van Woudenbergh E, Shin S, Karpinski W, Hsiao JC, Casadevall A, Bryson BD, Cavacini L, Grace PS, Alter G, Fortune SM -
Distinctive Antibody Responses to Mycobacterium Tuberculosis in Pulmonary and Brain Infection
BrainSpatola M, Nziza N, Irvine EB, Cizmeci D, Jung W, Van LH, Nhat LTH, Ha VTN, Phu NH, Ho DTN, Thwaites GE, Lauffenburger DA, Fortune S, Thuong NTT, Alter G -
Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review.
AtherosclerosisKumarapperuma H, Chia ZJ, Malapitan SM, Wight TN, Little PJ, Kamato D -
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
DiabetesGreenbaum CJ, Nepom GT, Wood-Heickman LK, Wherrett DK, DiMeglio LA, Herold KC, Krischer JP -
Fc-engineered Antibodies Leverage Neutrophils to Drive Control of Mycobacterium Tuberculosis
Nat MicrobiolIrvine EB, Nikolov A, Khan MZ, Peters JM, Lu R, Sixsmith J, Wallace A, van Woudenbergh E, Shin S, Karpinski W, Hsiao JC, Casadevall A, Bryson BD, Cavacini L, Grace PS, Alter G, Fortune SM -
T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.
bioRxivDeBerg HA, Fahning ML, Varkhande SR, Schlenker JD, Schmitt WP, Gupta A, Singh A, Gratz IK, Carlin JS, Campbell DJ, Morawski PA -
Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at-risk for type 1 diabetes.
The Journal of Clinical InvestigationLledó-Delgado A, Preston-Hurlburt P, Currie S, Clark P, Linsley PS, Long SA, Liu C, Koroleva G, Martins AJ, Tsang JS, Herold KC -
A splice of life: the discovery, function, and clinical implications of FOXP3 isoforms in autoimmune disease.
International ImmunologyWeinstein KN, Domeier PP, Ziegler SF -
Home and school pollutant exposure, respiratory outcomes, and influence of historical redlining.
The Journal of Allergy and Clinical ImmunologyJung KH, Argenio KL, Jackson DJ, Miller RL, Perzanowski MS, Rundle AG, Bacharier LB, Busse WW, Cohen RT, Visness CM, Gill MA, Gruchalla RS, Hershey GK, Kado RK, Sherenian MG, Liu AH, Makhija MM, Pillai DK, Rivera-Spoljaric K, Gergen PJ, Altman MC, Sandel MT, Sorkness CA, Kattan M, Lovinsky-Desir S -
Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19.
PLoS OneHolton SE, Mitchem M, Chalian H, Pipavath S, Morrell ED, Bhatraju PK, Hamerman JA, Speake C, Malhotra U, Wurfel MM, Ziegler SE, Mikacenic C -
Transitioning to stage 3 type 1 diabetes: when to start insulin
Lancet Diabetes EndocrinolBesser REJ, Griffin KJ -
Precision treatment of beta-cell monogenic diabetes: a systematic review
Commun Med (Lond)Naylor RN, Patel KA, Kettunen JLT, Männistö JME, Støy J, Beltrand J, Polak M, Vilsbøll T, Greeley SAW, Hattersley AT, Tuomi T -
Immune markers of severe acute pancreatitis.
Current Opinion in GastroenterologyLee PJ, Papachristou GI, Speake C, Lacy-Hulbert A
